Cargando…
PATH-02. Using DNA methylation profiling to define tumor type and appropriate treatment: a case report and review of the literature of a rare CNS CIC altered sarcoma
The utilization of methylation profiling is increasingly becoming part of the standard evaluation for high-grade malignancies. CNS primary tumors with CIC alteration are a recently recognized CNS tumor entity identified via DNA methylation profiling of primitive neuroectodermal tumors (PNET). PNETs...
Autores principales: | Brodwater, William, Wilson, Yelena, Judd, Alexis, Rush, Sarah, Wright, Erin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165123/ http://dx.doi.org/10.1093/neuonc/noac079.586 |
Ejemplares similares
-
PATH-05 Challenge and clinical relevance of a non-matching classifier output in genome-wide DNA methylation analysis for CNS neoplasms in pediatric and adolescent patients
por: Drexler, Richard, et al.
Publicado: (2022) -
PATH-04. Array-based global DNA Methylation profiling of mouse brain tumors allows comparison to human tumors
por: Schoof, Melanie, et al.
Publicado: (2022) -
PATH-07. Diagnostic and therapeutic value of cerebrospinal fluid biopsy in pediatric brain tumors
por: Li, Shaoqun, et al.
Publicado: (2022) -
PATH-06. Molecular subgrouping of medulloblastoma via low-depth whole genome bisulfite sequencing
por: Thompson, Dean, et al.
Publicado: (2022) -
PATH-01. Infant-Type Hemispheric Glioma: New Molecular Alterations and Precision-Medicine Treatment
por: Hu, Wanming, et al.
Publicado: (2022)